11 results  1 of 1 

1 The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma
Jihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun Shim
J Liver Cancer.2022;22(1):40-50.   Published online 2022 March 17     DOI: http://dx.doi.org/10.17998/jlc.2022.03.06
      
2 Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management
Abdulrazzak Zarifa, Jin Wan Kim, Juan Lopez-Mattei, Nicolas Palaskas, Cezar Iliescu, Peter Y. Kim
Korean Circ J.2021;51(7):579-597.   Published online 2021 May 21     DOI: http://dx.doi.org/10.4070/kcj.2021.0089
      
3 Immune-related Adverse Events: Overview and Management Strategies for the Use of Immune Checkpoint Inhibitors
Hei-Cheul Jeung, Se Eung Oh, Jee Hung Kim
J Rheum Dis.2019;26(4):221-234.   Published online 2019 October 31     DOI: http://dx.doi.org/10.4078/jrd.2019.26.4.221
   
4 Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience
Alice Indini, Lorenza Di Guardo, Carolina Cimminiello, Domenica Lorusso, Francesco Raspagliesi, Michele Del Vecchio
J Gynecol Oncol.2019;30(6):e94.  Published online 2019 May 13     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e94
      
5 Evaluation of expression patterns of feline CD28 and CTLA-4 in feline immunodeficiency virus (FIV)-infected and FIV antigen-induced PBMC
In Soo Choi, Han Sang Yoo, Ellen W Collisson
J Vet Sci.2000;1(2):97-103.   Published online 2019 February 13     DOI: http://dx.doi.org/10.4142/jvs.2000.1.2.97
      
6 Current Trends in Glioblastoma Multiforme Treatment: Radiation Therapy and Immune Checkpoint Inhibitors
Sarah Nicholas, Dimitris Mathios, Jacob Ruzevick, Christopher Jackson, Isaac Yang, Michael Lim
Brain Tumor Res Treat.2013;1(1):2-8.   Published online 2013 April 30     DOI: http://dx.doi.org/10.14791/btrt.2013.1.1.2
      
7 Functional Characteristics of C-terminal Lysine to Cysteine Mutant Form of CTLA-4Ig
Bongi Kim, Jun-Seop Shin, Chung-Gyu Park
Immune Netw.2013;13(1):16-24.   Published online 2013 February 28     DOI: http://dx.doi.org/10.4110/in.2013.13.1.16
      
8 T-Cell Dysfunction and Inhibitory Receptors in Hepatitis C Virus Infection
Jino Lee, William I. Suh, Eui-Cheol Shin
Immune Netw.2010;10(4):120-125.   Published online 2010 August 31     DOI: http://dx.doi.org/10.4110/in.2010.10.4.120
      
9 Role of N-terminal Hydrophilic Amino Acids in Molecular Translocation of CTLA-4 to Cell Surface
Ji Woong Han, Hye Ja Lee, Jin Mi Kim, Eun Young Choi, Hyun Joo Chung, Soo Bin Lim, Jang Won Choi, Yong Hoon Chung
Immune Netw.2002;2(2):102-108.   Published online 2002 June 30     DOI: http://dx.doi.org/10.4110/in.2002.2.2.102
      
10 Identification of SAP as a CTLA-4 Binding Molecule: a Role of SAP in CTLA-4 Signaling Proposed
Kyung Mi Lee
Immune Netw.2002;2(2):72-78.   Published online 2002 June 30     DOI: http://dx.doi.org/10.4110/in.2002.2.2.72
      
11 Characterization of CTLA-4 Antigen Expression Identification of Molecules Composing Intracellular CTLA-4 Multiprotein Complex
Dae Cheol Rhim, Yong Hoon Chung
Immune Netw.2002;2(1):35-40.   Published online 2002 March 31     DOI: http://dx.doi.org/10.4110/in.2002.2.1.35
      

 1 of 1